Dymicron Announces First Patient Enrolled in Triadyme-C IDE Clinical Trial
Orem
Archived
•
January 15, 2026
•
OREM, Utah, Jan. 15, 2026 /PRNewswire/ -- Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced the successful enrollment and treatment of the first patient in its Triadyme®-C Investigational Device Exemption (IDE) clinical trial. This milestone…
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
"Because adventure is exploring the unknown"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Monetize your website or boost your business with Code-Oryx. Join the network today!"